Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Wound Closure Strips are hypoallergenic adhesive strips used to seal wounds, incisions and lacerations, and are ideal for joints by securing the skin close together, thus eliminating the requirement of surface stitches or staples. GlobalData uses proprietary data and analytics to provide a comprehensive report on the wound closure strips devices market, including market shares of different players within the UK. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the wound closure strips market in the UK was 3M followed by Smith & Nephew, BSN medical, Cardinal Health, Urgo, Medline Industries, Paul Hartmann, Lohmann & Rauscher and DeRoyal Industries.
Wound Closure Strips are majorly used in surgical and trauma cases. The wound therefore can heal by more natural means. The usage of wound closure strips is negligible in the treatment of chronic wound and burn cases.
The value of the wound closure strips devices market within the UK was expected to be over $4m in 2023.
For the latest complete market share analysis of wound closure strips device market in the UK, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
